Catalog No.
DHD09601
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Humanized
Isotype
IgG1-kappa
Clonality
Monoclonal
Target
T-cell growth factor P40, Cytokine P40, IL9, Interleukin-9, IL-9
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P15248
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
7F3com-2H2, MEDI-528, CAS: 909875-08-7
Clone ID
Enokizumab
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma, PMID: 24050312
Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma, PMID: 21428906
MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma, PMID: 20373267
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma, PMID: 21356110
Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers, PMID: 19446146
Mapping knowledge structure and research of the biologic treatment of asthma: A bibliometric study., PMID:36845128
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma., PMID:24050312
Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma., PMID:21428906
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma., PMID:21356110
MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma., PMID:20373267
Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers., PMID:19446146
For research use only. Not for human or drug use.
